KEY Tronic (KTCC) VP awarded 8,992 restricted stock units
Rhea-AI Filing Summary
Mark R. Courtney, Vice President of Supply Chain at KEY Tronic Corp (KTCC), was granted 8,992 restricted stock units on 08/21/2025. Each unit represents the contingent right to receive one share of common stock and the award carries a $0 per-share purchase price. The restricted stock units vest in three equal annual installments on August 21, 2026, 2027 and 2028, subject to time-based vesting conditions. Following the reported transaction, Mr. Courtney beneficially owns 14,535 shares of common stock, reported as direct ownership.
Positive
- 8,992 restricted stock units granted to the reporting person
- RSUs vest in three equal annual installments on August 21, 2026, 2027 and 2028
- Each RSU represents one share of common stock
Negative
- None.
Insights
TL;DR: Officer received time-vested RSUs aligning compensation with future share ownership over three years.
The report documents an award of 8,992 restricted stock units to the company’s Vice President of Supply Chain, vesting in three equal annual installments beginning August 21, 2026. The units are described as contingent rights to one share each and carry a reported price of $0, consistent with equity grant reporting rather than a cash purchase. The filing shows post-transaction direct beneficial ownership of 14,535 shares. From a compensation perspective, the structure is a standard time-based retention and alignment tool for senior staff; the filing itself does not disclose performance conditions, accelerated vesting, or cash proceeds.
TL;DR: Routine insider equity grant disclosed; no unusual terms or exceptions are reported.
The Form 4 discloses a routine equity grant to an executive officer with explicit vesting dates and quantities: 8,992 restricted stock units vesting in equal installments on August 21 of 2026, 2027 and 2028. The filing indicates direct beneficial ownership of 14,535 shares following the grant and includes the reporting person’s title and address. There is no indication in the filing of derivative instruments, sales, or transactions other than the award, nor any amendments or special plan references beyond the grant itself.